TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GNLX

Genelux Corporation

Healthcare · Biotechnology

2.60$ +1.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Genelux Corporation (GNLX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 19 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GNLX
Line item 2019 2020 2021 2022 2023 2024 2025
3.3 14 8.1 5.5 28 35 19
0.6 11 5.8 1.9 24 32 15
0.4 11 4.5 0.4 9.4 8.6 5.3
0.4 11 4.5 0.4 23 31 15
2.7 2.5 2.2
28 37 41 41 8.4 8.4 7.5
15 14 22 32 6.6 6.9 6.2
4.6 3.9 6.6 17 0.7 0.3 0.4
3.6 0.9 4.5 6.8 3.8 5.6 4.4
22 18 8.5
-25 -23 -33 -36 19 26 12
-155 -168 -185 -190 -222 -251 -284
24 24 24 25 24 31 37

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?